Dolby Laboratories (NYSE:DLB) Shares Unloaded Rep. Lisa C. McClain

Representative Lisa C. McClain (R-Michigan) recently sold shares of Dolby Laboratories (NYSE:DLB). In a filing disclosed on September 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Dolby Laboratories stock on August 4th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $50,001 – $100,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 8/28/2025.
• Purchased $1,001 – $15,000 in shares of ACI Worldwide (NASDAQ:ACIW) on 8/19/2025.
• Purchased $1,001 – $15,000 in shares of HCA Healthcare (NYSE:HCA) on 8/19/2025.
• Sold $1,001 – $15,000 in shares of Amedisys (NASDAQ:AMED) on 8/18/2025.
• Purchased $1,001 – $15,000 in shares of Kite Realty Group Trust (NYSE:KRG) on 8/13/2025.
• Sold $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 8/13/2025.
• Purchased $1,001 – $15,000 in shares of JD.com (NASDAQ:JD) on 8/13/2025.
• Sold $1,001 – $15,000 in shares of Trade Desk (NASDAQ:TTD) on 8/13/2025.
• Sold $1,001 – $15,000 in shares of US Foods (NYSE:USFD) on 8/13/2025.
• Purchased $1,001 – $15,000 in shares of Agree Realty (NYSE:ADC) on 8/13/2025.

Dolby Laboratories Stock Down 0.8%

Shares of Dolby Laboratories stock opened at $71.53 on Monday. Dolby Laboratories has a twelve month low of $68.24 and a twelve month high of $89.66. The company has a market cap of $6.86 billion, a price-to-earnings ratio of 26.20 and a beta of 0.93. The company’s 50 day moving average is $73.38 and its 200 day moving average is $75.11.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The business had revenue of $315.55 million during the quarter, compared to analysts’ expectations of $305.23 million. During the same period in the prior year, the company earned $0.71 earnings per share. The firm’s revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. Sell-side analysts expect that Dolby Laboratories will post 2.94 EPS for the current fiscal year.

Dolby Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 20th. Investors of record on Tuesday, August 12th were given a dividend of $0.33 per share. The ex-dividend date was Tuesday, August 12th. This represents a $1.32 dividend on an annualized basis and a yield of 1.8%. Dolby Laboratories’s dividend payout ratio is 48.35%.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 39,875 shares of the firm’s stock in a transaction dated Tuesday, July 15th. The shares were sold at an average price of $74.82, for a total transaction of $2,983,447.50. Following the transaction, the chief executive officer owned 114,725 shares of the company’s stock, valued at approximately $8,583,724.50. This trade represents a 25.79% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $74.92, for a total transaction of $524,440.00. Following the transaction, the senior vice president directly owned 70,435 shares in the company, valued at $5,276,990.20. This trade represents a 9.04% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 124,366 shares of company stock worth $9,144,463 in the last three months. Insiders own 38.39% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Alpine Bank Wealth Management purchased a new position in Dolby Laboratories in the 1st quarter worth about $25,000. Cheviot Value Management LLC purchased a new position in Dolby Laboratories during the 1st quarter valued at about $27,000. MAI Capital Management increased its position in Dolby Laboratories by 87.1% during the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock valued at $28,000 after purchasing an additional 162 shares during the period. Caitong International Asset Management Co. Ltd purchased a new position in Dolby Laboratories during the 1st quarter valued at about $29,000. Finally, Allworth Financial LP increased its position in Dolby Laboratories by 590.4% during the 2nd quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock valued at $37,000 after purchasing an additional 431 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Rosenblatt Securities reaffirmed a “buy” rating and set a $95.00 target price on shares of Dolby Laboratories in a report on Friday, August 1st. Barrington Research reaffirmed an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 12th. Baird R W raised shares of Dolby Laboratories to a “hold” rating in a research note on Friday, September 5th. Tigress Financial increased their price objective on shares of Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a research note on Friday, August 15th. Finally, Wall Street Zen raised shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research note on Saturday, August 30th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $95.75.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.